GenMark Diagnostics ROA 2010-2020 | GNMK

Current and historical return on assets (ROA) values for GenMark Diagnostics (GNMK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. GenMark Diagnostics ROA for the three months ending March 31, 2020 was -38.11%.
GenMark Diagnostics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-03-31 $-0.04B $0.11B -42.53%
2019-12-31 $-0.05B $0.11B -49.47%
2019-09-30 $-0.05B $0.09B -54.14%
2019-06-30 $-0.05B $0.09B -52.17%
2019-03-31 $-0.05B $0.10B -54.88%
2018-12-31 $-0.05B $0.09B -51.91%
2018-09-30 $-0.05B $0.09B -51.18%
2018-06-30 $-0.06B $0.10B -50.43%
2018-03-31 $-0.06B $0.11B -46.46%
2017-12-31 $-0.06B $0.12B -53.80%
2017-09-30 $-0.06B $0.13B -57.28%
2017-06-30 $-0.06B $0.15B -60.64%
2017-03-31 $-0.05B $0.06B -70.99%
2016-12-31 $-0.05B $0.08B -70.34%
2016-09-30 $-0.05B $0.09B -66.90%
2016-06-30 $-0.05B $0.06B -67.65%
2016-03-31 $-0.05B $0.06B -61.43%
2015-12-31 $-0.04B $0.07B -51.85%
2015-09-30 $-0.04B $0.08B -48.70%
2015-06-30 $-0.04B $0.08B -44.81%
2015-03-31 $-0.04B $0.09B -41.13%
2014-12-31 $-0.04B $0.09B -37.96%
2014-09-30 $-0.04B $0.10B -37.19%
2014-06-30 $-0.04B $0.11B -35.59%
2014-03-31 $-0.04B $0.11B -36.97%
2013-12-31 $-0.03B $0.12B -36.56%
2013-09-30 $-0.03B $0.13B -35.22%
2013-06-30 $-0.02B $0.06B -35.66%
2013-03-31 $-0.02B $0.06B -30.55%
2012-12-31 $-0.02B $0.07B -37.86%
2012-09-30 $-0.02B $0.07B -43.19%
2012-06-30 $-0.02B $0.07B -48.94%
2012-03-31 $-0.02B $0.03B -55.76%
2011-12-31 $-0.02B $0.04B -61.94%
2011-09-30 $-0.02B $0.04B -64.79%
2011-06-30 $-0.02B $0.05B -69.84%
2011-03-31 $-0.02B $0.02B -77.78%
2010-12-31 $-0.02B $0.03B -88.37%
2010-09-30 $-0.02B $0.03B -137.70%
2010-06-30 $-0.02B $0.03B -266.67%
2010-03-31 $-0.02B $0.00B inf%
2009-12-31 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.924B $0.088B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $144.509B 29.34
Intuitive Surgical (ISRG) United States $67.694B 50.00
Edwards Lifesciences (EW) United States $42.875B 36.04
DexCom (DXCM) United States $37.617B 175.58
ALCON INC (ALC) Switzerland $28.696B 32.12
IDEXX Laboratories (IDXX) United States $28.432B 66.95
Fresenius Medical Care AG KGaA (FMS) Germany $26.420B 18.00
Olympus (OCPNY) Japan $25.621B 52.11
Teleflex (TFX) United States $17.092B 31.66
Sysmex ADR (SSMXY) Japan $15.528B 43.76
Hologic (HOLX) United States $14.940B 23.52
SONOVA HOLDING (SONVY) Switzerland $13.290B 0.00
STERIS (STE) Ireland $13.083B 27.31
Masimo (MASI) United States $12.540B 68.15
ABIOMED (ABMD) United States $11.884B 63.73
Varian Medical Systems (VAR) United States $11.115B 26.96
SARTORIUS AG (SARTF) Germany $9.169B 78.82
Penumbra (PEN) United States $6.592B 253.99
Tandem Diabetes Care (TNDM) United States $5.925B 0.00
Globus Medical (GMED) United States $4.796B 30.35
Integra LifeSciences Holdings (IART) United States $4.134B 18.96
Nevro (NVRO) United States $4.004B 0.00
Wright Medical Group (WMGI) Netherlands $3.828B 594.00
Elekta AB (EKTAY) Sweden $3.572B 27.50
Nihon Kohden (NHNKY) Japan $2.820B 0.00
LivaNova (LIVN) United Kingdom $2.478B 18.68
Integer Holdings (ITGR) United States $2.373B 14.66
OPKO Health (OPK) United States $2.371B 0.00
Cantel Medical (CMD) United States $1.877B 21.72
Glaukos (GKOS) United States $1.709B 0.00
ShockWave Medical (SWAV) United States $1.512B 0.00
Luminex (LMNX) United States $1.504B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.449B 28.09
Veracyte (VCYT) United States $1.387B 0.00
Silk Road Medical (SILK) United States $1.334B 0.00
Mesa Laboratories (MLAB) United States $0.954B 50.45
Accelerate Diagnostics (AXDX) United States $0.877B 0.00
Inogen (INGN) United States $0.800B 47.72
Tactile Systems Technology (TCMD) United States $0.786B 99.68
OrthoPediatrics (KIDS) United States $0.786B 0.00
Natus Medical (NTUS) United States $0.742B 18.29
CryoLife (CRY) United States $0.740B 103.26
Quotient (QTNT) Switzerland $0.625B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.618B 24.95
Pacific Biosciences Of California (PACB) United States $0.577B 0.00
Si-Bone (SIBN) United States $0.458B 0.00
AxoGen (AXGN) United States $0.457B 0.00
Intersect ENT (XENT) United States $0.447B 0.00
Vermillion (AWH) United States $0.394B 0.00
AngioDynamics (ANGO) United States $0.389B 25.83
TransMedics (TMDX) United States $0.372B 0.00
ViewRay (VRAY) United States $0.345B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.339B 0.00
Alphatec Holdings (ATEC) United States $0.318B 0.00
Fluidigm (FLDM) United States $0.317B 0.00
Stereotaxis (STXS) United States $0.297B 0.00
Semler Scientific (SMLR) United States $0.296B 32.75
IRadimed (IRMD) United States $0.289B 31.12
SeaSpine Holdings (SPNE) United States $0.284B 0.00
RTI Surgical (RTIX) United States $0.219B 0.00
Sientra (SIEN) United States $0.205B 0.00
Accuray (ARAY) United States $0.196B 0.00
T2 Biosystems (TTOO) United States $0.167B 0.00
CRH Medical (CRHM) Canada $0.160B 112.00
Electromed (ELMD) United States $0.130B 33.35
Restoration Robotics (VERO) Canada $0.113B 0.00
Spectral Diagnostics (EDTXF) Canada $0.098B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.074B 36.57
Bioanalytical Systems (BASI) United States $0.057B 0.00
MRI Interventions (CLPT) United States $0.056B 0.00
Ekso Bionics Holdings (EKSO) United States $0.056B 0.00
ConforMIS (CFMS) United States $0.056B 0.00
Sensus Healthcare (SRTS) United States $0.050B 0.00
Allied Healthcare Products (AHPI) United States $0.046B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.043B 0.00
Apollo Endosurgery (APEN) United States $0.035B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Delcath Systems (DCTH) United States $0.027B 0.00
Neovasc (NVCN) Canada $0.027B 0.00
DarioHealth (DRIO) Israel $0.024B 0.00
Second Sight Medical Products (EYES) United States $0.022B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.020B 0.00
Sunshine Heart Inc (CHFS) United States $0.019B 0.00
Helius Medical Technologies (HSDT) United States $0.018B 0.00
TransEnterix (TRXC) United States $0.018B 0.00
ReWalk Robotics (RWLK) Israel $0.018B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Xtant Medical Holdings (XTNT) United States $0.013B 0.00
Dynatronics (DYNT) United States $0.013B 0.00
American Shared Hospital Services (AMS) United States $0.012B 42.20
Lianluo Smart (LLIT) China $0.011B 0.00
Avinger (AVGR) United States $0.010B 0.00
Nanovibronix (NAOV) United States $0.009B 0.00
Viveve Medical (VIVE) United States $0.009B 0.00
Ra Medical Systems (RMED) United States $0.007B 0.00
OBALON THERPTCS (OBLN) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.002B 0.00